Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
61.2M
-
Shares change
-
+4.87M
-
Total reported value, excl. options
-
$2.76B
-
Value change
-
+$192M
-
Put/Call ratio
-
0.8
-
Number of buys
-
97
-
Number of sells
-
-99
-
Price
-
$45.18
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2019
256 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2019.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.2M shares
of 101M outstanding shares and own 60.61% of the company stock.
Largest 10 shareholders include FMR LLC (9.58M shares), VANGUARD GROUP INC (7.28M shares), BlackRock Inc. (6.23M shares), STATE STREET CORP (3.04M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (2.72M shares), JANUS HENDERSON GROUP PLC (2.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.48M shares), FIRST TRUST ADVISORS LP (2.05M shares), FARALLON CAPITAL MANAGEMENT LLC (1.7M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.7M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.